- Home
- IDA vs CORT Comparison
IDA vs CORT Comparison
Compare IDA & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDA
- CORT
- Stock Information
- Founded
- IDA 1915
- CORT 1998
- Country
- IDA United States
- CORT United States
- Employees
- IDA N/A
- CORT N/A
- Industry
- IDA Electric Utilities: Central
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- IDA Utilities
- CORT Health Care
- Exchange
- IDA Nasdaq
- CORT Nasdaq
- Market Cap
- IDA 7.0B
- CORT 7.6B
- IPO Year
- IDA N/A
- CORT N/A
- Fundamental
- Price
- IDA $131.91
- CORT $71.59
- Analyst Decision
- IDA Buy
- CORT Strong Buy
- Analyst Count
- IDA 7
- CORT 4
- Target Price
- IDA $133.00
- CORT $139.00
- AVG Volume (30 Days)
- IDA 414.6K
- CORT 949.8K
- Earning Date
- IDA 10-30-2025
- CORT 11-04-2025
- Dividend Yield
- IDA 2.63%
- CORT N/A
- EPS Growth
- IDA 6.48
- CORT N/A
- EPS
- IDA 5.70
- CORT 1.11
- Revenue
- IDA $1,809,996,000.00
- CORT $716,080,000.00
- Revenue This Year
- IDA $5.11
- CORT $28.85
- Revenue Next Year
- IDA $8.59
- CORT $34.98
- P/E Ratio
- IDA $23.49
- CORT $64.65
- Revenue Growth
- IDA N/A
- CORT 25.71
- 52 Week Low
- IDA $100.10
- CORT $42.01
- 52 Week High
- IDA $138.03
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- IDA 45.46
- CORT 37.81
- Support Level
- IDA $133.11
- CORT $70.89
- Resistance Level
- IDA $137.04
- CORT $73.09
- Average True Range (ATR)
- IDA 2.29
- CORT 3.23
- MACD
- IDA -0.66
- CORT -0.95
- Stochastic Oscillator
- IDA 15.06
- CORT 19.70
About IDA IDACORP Inc.
Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.